NASDAQ · Financial Statements

Alpine Immune Sciences, Inc. (ALPN) Financial Statements

$64.97 NASDAQ: ALPN Market Cap $4.46B

Alpine Immune Sciences, Inc. most recently reported annual revenue of $59.0M, net profit of $-32.0M, revenue has compounded at 126.0% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20192020202120222023
Revenue$2.0M$9.0M$23.0M$30.0M$59.0M
Operating Profit$-44.0M$-29.0M$-50.0M$-58.0M$-44.0M
Net Profit$-43.0M$-28.0M$-50.0M$-58.0M$-32.0M
EPS$-2.32$-1.34$-1.98$-1.73$-0.64
Op Margin-2504.3%-308.0%-212.7%-193.4%-75.2%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$54.0M$144.0M$256.0M$287.0M$380.0M
Total Liabilities$25.0M$82.0M$135.0M$107.0M$52.0M
Cash$16.0M$35.0M$68.0M$13.0M$44.0M
Borrowings$16.0M$23.0M$20.0M$14.0M$10.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-35.0M$30.0M$-15.0M$-44.0M$-79.0M
Investing Cash Flow$16.0M$-74.0M$-53.0M$-114.0M$-111.0M
Financing Cash Flow$24.0M$61.0M$101.0M$103.0M$165.0M
Net Cash Flow$6.0M$19.0M$33.0M$-55.0M$31.0M
Free Cash Flow$-36.0M$29.0M$-15.0M$-44.0M$-79.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.28
EV / EBITDA-140.82
FCF Yield-1.78%
Quick Ratio7.87
Interest Coverage-451.53
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
ALPN Overview ALPN Dividend Run Stock Screener